← Eichor
Study identifier: NCT07561827 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery

Condition: Adolescent Idiopathic Scoliosis (AIS) · Neuromuscular Scoliosis · Adolescent Idiopathic Scoliosis  ·  Sponsor: University of California, San Francisco

PhasePhase 3
Planned participants42
Who can joinAll sexes, 10 Years to 18 Years
Healthy volunteersNo

About this study

This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery. The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.

This description comes directly from the study's public registry record.

Talk to the study team

Tripta Rughwani  ·  415-353-4701  ·  tripta.rughwani@ucsf.edu

Stephanie Chu  ·  415-353-1454  ·  stephanie.chu4@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California San FranciscoSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07561827